Q4 2018 13F Holders as of 31 Dec 2018
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
49,633,071
-
Total 13F shares
-
35,195,489
-
Share change
-
-455,628
-
Total reported value
-
$716,303,054
-
Put/Call ratio
-
191%
-
Price per share
-
$20.35
-
Number of holders
-
137
-
Value change
-
-$227,829,815
-
Number of buys
-
67
-
Number of sells
-
90
Institutional Holders of PUMA BIOTECHNOLOGY, INC. - Common Stock (PBYI) as of Q4 2018
As of 31 Dec 2018,
PUMA BIOTECHNOLOGY, INC. - Common Stock (PBYI) was held by
137 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
35,195,489 shares.
The largest 10 holders included
STATE STREET CORP, Vanguard Group Inc, BlackRock Inc., ORBIMED ADVISORS LLC, JANUS HENDERSON GROUP PLC, FEDERATED INVESTORS INC /PA/, GREAT POINT PARTNERS LLC, Sarissa Capital Management LP, MILLENNIUM MANAGEMENT LLC, and Camber Capital Management LP.
This page lists
137
institutional shareholders reporting positions in this security
for the Q4 2018 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.